Turnstone Biologics
NASDAQ: TSBX
Developing cancer therapies that activate T-cell responses through immuno-oncology.
Developing cancer therapies that activate T-cell responses through immuno-oncology.
F-Prime Team
Sector
Life SciencesCategory
TherapeuticsLocation
Ottawa, CanadaInitial Investment
2016Turnstone Biologics (NASDAQ: TSBX) is transforming patient care with a new class of targeted viral immunotherapies to fight cancer.